It is not known whether CPI-1429 is able to cross the BBB
We were exploring ways of developing peptides that bind selectively, and we were very successful at that, but then we confronted the problem that our short, 23-residue peptides are not promising therapeutic candidates primarily because they cannot get into cells, Keating says
Premature discontinuation before reaching therapeutic doses or adequate treatment duration prevents full pharmacological effect
Now lets take a closer look at what to avoid when taking glutathione in order to achieve the best results and prevent side effects
C., Wunschmann, J., Lendzian, K
Grech O, Mollan SP, Wakerley BR, Alimajstorovic Z, Lavery GG, Sinclair AJ